|Articles|January 23, 2015

PHT Offers Rater Training in Three Instruments

Author(s)Applied Clinical Trials Editorial Staff

The pharmaceutical industry is further optimizing the collection of high quality electronic patient reported outcomes (ePROs) data for clinical research, with PHT Corporation Rater Training programs

On Monday, January 26, eCOA systems provider PHT Corporation, will announce its rater training programs inclusive of instruction on each instrument’s electronic implementation for the Clinician Columbia-Suicide Severity Rating Scale (C-SSRS) Screening/Baseline (SB) and Since Last Visit (SLV) Adult and Pediatric versions; the Mini International Neurosychiatric Interview Questionnaire (M.I.N.I.); and the Sheehan Suicidality Tracking Scale (Sheehan-STS). Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

PHT Offers Rater Training in Three Instruments

Related Content

Beyond Patient Centricity: What Rare Disease Research Gets Right

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

Why Time Savings Is the Largest Driver of RBQM's Financial Value

Trending on Applied Clinical Trials Online

Beyond Patient Centricity: What Rare Disease Research Gets Right

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files